Results 21 to 30 of about 52,240,321 (193)

Rosalind and Morris Goodman Cancer Research Centre Annual Symposium | May 6-7, 2021

McGill Journal of Medicine, 2021
n ...
The Rosalind and Morris Goodman Cancer Research Centre (GCRC)
doaj  

Altmetric vs. Citations: An In-Depth Analysis of Top-tier Cancer Research [PDF]

International Journal of Information Science and Management
In this study, we aimed to comprehensively analyze the altmetric indices of 1000 highly cited articles in the field of cancer, considering the growing importance of social media-based indicators as complementary tools alongside traditional bibliometric ...
Mohammad Ahmadian, Hamzeh Mazaherilaghab, Hossein Vakilimofrad   +2 more
doaj   +1 more source

Expert consensus on the clinical application of PI3K/AKT/mTOR inhibitors in the treatment of advanced breast cancer

Cancer Innovation, 2022
Phosphoinositide 3‐kinase (PI3K)/protein kinase B (PKB or AKT)/mammalian target of rapamycin (mTOR) signaling pathway (PAM pathway) plays an important role in the development of breast cancer and are closely associated with the resistance to endocrine ...
The Society of Clinical Research of Oncology Medications of China Anticancer Association, Breast Cancer Expert Committee of National Cancer Quality Control Center, Boao Cancer Innovation Institute   +2 more
doaj   +1 more source

Cancer Research UK Cancer Awareness Measures, 2017

, 2020
copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller, J., Ramirez, A.,
Cancer Research UK
core   +2 more sources

Disulfide-Modified Mesoporous Silica Nanoparticles for Biomedical Applications

Crystals, 2023
Mesoporous silica nanoparticles (MSNs) are highly porous carriers used in drug and gene delivery research for biomedical applications due to their high surface area, narrow particle size distribution, and low toxicity.
Melissa Venedicto, Jake Carrier, Ha Na, Chen-Yu Chang, Daniela R. Radu, Cheng-Yu Lai   +5 more
doaj   +1 more source

HER3 Is an Actionable Target in Advanced Prostate Cancer.

, 2021
It has been recognized for decades that ERBB signaling is important in prostate cancer, but targeting ERBB receptors as a therapeutic strategy for prostate cancer has been ineffective clinically.
Bertan, C, Crespo, M, Guo, C, D'Ambrosio, M, Sharp, A, Rekowski, J, Swain, A, Carreira, S, Paschalis, A, Troiani, M, Ning, J, Gurel, B, de Bono, J, Sumanasuriya, S, PCF/SU2C International Prostate Cancer Dream Team,, Gil, V, Christova, R, Califano, A, Seed, G, Brina, D, Workman, P, Vasciaveo, A, Pereira, R, Dolling, D, Yuan, W, Flohr, P, Sheehan, B, Fowler, G, Rescigno, P, Neeb, A, Ferreira, A, Riisnaes, R, Alajati, A, Alimonti, A, Miranda, S, Buroni, L, Tunariu, N, Lambros, M, Aversa, C, Figueiredo, I, Shen, MM, Bianchini, D, Welti, J, Clarke, M, Boysen, G   +44 more
core   +1 more source

Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.

, 2007
Association studies in large series of breast cancer patients can be used to identify single-nucleotide polymorphisms (SNP) contributing to breast cancer susceptibility.
Pharoah, Paul DP, Hogervorst, Frans BL, Dunning, Alison M, Nevanlinna, Heli A, Blomqvist, Carl,, Tommiska, Johanna, Healey, Catherine S, Pharoah, Paul D P, Tollenaar, Rob A E M, Reincke, Scarlett, Peto, Julian, Blomqvist, Carl, Van't Veer, Laura J, Johnson, Nichola, Fletcher, Olivia, Tollenaar, Rob AEM, Broeks, Annegien, Schmidt, Marjanka K, Braaf, Linde M, Hogervorst, Frans B L, Breast Cancer Association Consortium, Easton, Douglas F, Dörk, Thilo   +22 more
core   +1 more source

The association between periodontal disease and pancreatic cancer

, 2016
[[abstract]]Background: Despite years of research, the causes of pancreatic cancer have remained largely unknown. Periodontal disease (PD) is an emerging risk factor for various systemic diseases, including cancer.
Chang, JS;Tsai, CR;Shan, YS;Chen, LT
core   +1 more source

Cancer Research UK Cancer Awareness Measures, 2021: Special Licence Access

, 2023
copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller ...
Cancer Research UK
core   +2 more sources

The state of cancer research in fragile and conflict-affected settings in the Middle East and North Africa Region: A bibliometric analysis

Frontiers in Oncology, 2023
BackgroundCancer represents a disproportionate burden in LMICs, especially conflict-affected countries in the MENA region. Research output on cancer fails to match the growing burden in the region.
Zahi Abdul Sater, Theresa Farhat, Mohamed N. Elsayed, Yara Youssef, Marium Husain, Malak Kaddoura, Lubna Jaber, Deborah Mukherji, Ali Taher   +8 more
doaj   +1 more source